This is the authors' abstract. We don't add key points for this paper.
Mortality in Parkinson's disease remains increased despite low dose levodopa-carbidopa therapy and no additional benefit was gained from early use of bromocriptine. Duration of disease was similar to that in the era before levodopa.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hely et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: